Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2008 Dec;1(7):546–553. doi: 10.1158/1940-6207.CAPR-08-0015

Table 1.

Experimental groups to examine the effect of tamoxifen on the progression towards concurrent mammary and ovarian cancer.

Treatment Group CONT TAM CARC CARC+TAM
Ovarian treatment Vehicle Vehicle DMBA DMBA
Systemic treatment Vehicle Vehicle E2 E2
Tamoxifen treatment Vehicle Tamoxifen Vehicle Tamoxifen

CONT = vehicle-treated animals, TAM = tamoxifen-treated animals, and CARC = carcinogen-treated animals.